Atossa Therapeutics (ATOS)
Nasdaq • ATOS • US04962H7044
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 5.7% of free float sold short, 5.7 days to cover, cost to borrow 1.51%. Sign up for live short interest data.
Market Cap
20.3m USD | # 10395 in US
Volume
70.83k shares | 170.36k USD
Shares Outstanding
9.98m
Free Float Shares
99.65% | 9.94m
